The last few pages of the report show increasing sale and decreasing cost. Reasonable to assume furhter profit growth next year. If it doubles and a sector PE of 20 then this time next year Market cap should be around 24 million. $ times current value.
Whilst itr is still 2 away, the big kicker here is the hundred million dollar market for Liver Fibrosous. Because this is an auto generated scalable software business, last years costs were only $1.8 million.
After product development and sale costs, it could stay at that level and generate in excess of #100 million in saleS.
What a great business model. The money keeps chinging in for years on auto-pilot. Will still be a few years yet, but qa good growth stock for the super fund.
That means a valuation of around $6 in 5 years, good easy stroll from 2 cents over that time. Does not appear to be all that risky as they have already got experience and profits.
PoS.
smart business., page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
